(VIANEWS) – According to Innrs, a real-time financial asset buying rank, today’s top 10 financial assets are CBOE (VIX), DAX PERFORMANCE-INDEX (GDAXI), Gold (GC), Amazon (AMZN), QUALCOMM (QCOM), Regeneron Pharmaceuticals (REGN), Costco (COST), Tesla (TSLA), Moderna (MRNA), and JD.com (JD).

Today’s Innrs top 10 Financial Assets

Innrs Rank Financial Asset Score Est. Profit * Past Position *
1 CBOE (VIX) 50.64 28.3538% 33
2 DAX PERFORMANCE-INDEX (GDAXI) 49.52 -4.88526% 699
3 Gold (GC) 43.5 -2.01339% 6
4 Amazon (AMZN) 42.35 -2.69128% 6
5 QUALCOMM (QCOM) 40.61 -11.0643% 395
6 Regeneron Pharmaceuticals (REGN) 40.17 -5.2847% 149
7 Costco (COST) 39.07 -4.10684% 36
8 Tesla (TSLA) 38.98 20.7966% 101
9 Moderna (MRNA) 37.98 -6.72163% 154
10 JD.com (JD) 37.8 -1.23791% 124

* 30 Sessions

The Innrs Rank is an every-hour updated algorithm that provides automated buying tips for investors. Statistically, if an investor were to follow the Innrs Rank buying criteria and had invested on the Innrs top 10 financial assets present on this list, 30 days ago, that would result in an ROI of -1.85%.

According to the Innrs website, its rank includes (when available): “both historical data and
future (projected) data”, “growth and sales estimates, revenue, earnings, dividend yield, profit margin,
stochastic, volatility, RSI, moving average. premarket value, ROA, ROI, PE ratio, EPS, and more.”

1. CBOE (VIX) – Score: 50.64

CBOE is currently on bullish momentum. At 07:33 EST on Wednesday, 6 October, CBOE is at 23.73, 45.85% up since the last session’s close.

CBOE Range

About CBOE’s daily highs and lows, it’s 40.5% up from its trailing 30 days low of $16.89 and 17.58% down from its trailing 30 days high of $28.79.

Regarding CBOE’s yearly highs and lows, it’s 68.3% up from its 52-week low and 42.35% down from its 52-week high.

Volatility

CBOE’s last week, last month’s, and last quarter’s current volatility was 0.73%, 12.63%, and 9.76%, respectively.

CBOE’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.44% (last week), 16.59% (last month), and 9.76% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CBOE’s is considered to be overbought (>=80).

More news about CBOE.

2. DAX PERFORMANCE-INDEX (GDAXI) – Score: 49.52

DAX PERFORMANCE-INDEX is currently on bearish momentum. At 07:33 EST on Wednesday, 6 October, DAX PERFORMANCE-INDEX is at 14,850.82, 7.28% down since the last session’s close.

DAX PERFORMANCE-INDEX Range

About DAX PERFORMANCE-INDEX’s daily highs and lows, it’s 0.89% down from its trailing 30 days low of $14,983.80 and 6.76% down from its trailing 30 days high of $15,927.80.

Concerning DAX PERFORMANCE-INDEX’s yearly highs and lows, it’s 29.7% up from its 52-week low and 7.36% down from its 52-week high.

Volatility

DAX PERFORMANCE-INDEX’s last week, last month’s, and last quarter’s current volatility was a negative 0.69%, a negative 0.31%, and a positive 0.66%, respectively.

DAX PERFORMANCE-INDEX’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.69% (last week), 0.88% (last month), and 0.66% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DAX PERFORMANCE-INDEX’s is considered to be overbought (>=80).

More news about DAX PERFORMANCE-INDEX.

3. Gold (GC) – Score: 43.5

Gold is currently on bearish momentum. At 07:33 EST on Wednesday, 6 October, Gold is at $1,749.30 and 3.76% down since the last session’s close.

Gold Range

Concerning Gold’s daily highs and lows, it’s 1.438% up from its trailing 30 days low of $1,724.50 and 3.15% down from its trailing 30 days high of $1,806.20.

Volatility

Gold’s last week, last month’s, and last quarter’s current volatility was a positive 0.65%, a negative 0.15%, and a positive 0.57%, respectively.

Gold’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.83% (last week), 0.70% (last month), and 0.57% (last quarter), respectively.

Last news about Gold

  • Gold price forecast: xau/usd looks to test strong support at $1749 – confluence detector. According to FXStreet on Tuesday, 5 October, "Read: Gold Price Forecast: XAU/USD awaits acceptance below $1750 to resume the downside"

More news about Gold.

4. Amazon (AMZN) – Score: 42.35

Shares of Amazon slid 8.84% in 30 days from $3533.35 to $3,221.00 at 07:33 EST on Wednesday, following the last session’s upward trend. NASDAQ Composite is rising 1.25% to $14,433.83, after two consecutive sessions in a row of losses.

Amazon’s last close was $3,221.00, 14.63% below its 52-week high of $3,773.08.

Amazon’s Sales

Amazon’s sales growth is 16.1% for the present quarter and 13.9% for the next. The company’s growth estimates for the current quarter and the next is a negative 27.2% and a negative 9.9%, respectively.

Amazon’s Revenue

Year-on-year quarterly revenue growth grew by 43.8%, now sitting on 419.13B for the twelve trailing months.

Volatility

Amazon’s last week, last month’s, and last quarter’s current volatility was a negative 1.16%, a negative 0.45%, and a positive 0.96%, respectively.

Amazon’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.16% (last week), 0.94% (last month), and 0.96% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Amazon’s stock is considered to be overbought (>=80).

Amazon’s Stock Yearly Top and Bottom Value

Amazon’s stock is valued at $3,221.00 at 07:33 EST, way below its 52-week high of $3,773.08 and way higher than its 52-week low of $2,881.00.

Amazon’s Moving Average

Amazon’s worth is below its 50-day moving average of $3,371.50 and below its 200-day moving average of $3,365.28.

Previous days news about Amazon

  • Amazon turns negative for 2021 as higher yields add to pressure. According to Bloomberg Quint on Monday, 4 October, "Shares fell as much as 2.5% and were on track for a sixth straight negative session, the longest such streak for Amazon since an eight-day drop that ended in August 2019. "
  • Amazon CEO says video games could become the largest entertainment business. According to Bloomberg Quint on Tuesday, 5 October, "A week ago, Amazon released New World, an online computer game where archers and ax wielderscolonizea mythical land. "
  • Amazon ceo, citing ‘rougher’ patch with seattle, looks to ‘burbs. According to Bloomberg Quint on Tuesday, 5 October, "He added that he wouldn’t be surprised if Amazon opened other offices in additional cities in the region.", "A few years ago, Amazon stopped referring to Seattle as its hometown, instead citing the Puget Sound region, the Pacific Ocean inlet abutting Seattle and neighboring cities, as its headquarters. "
  • Amazon founder jeff bezos invests in Indonesian ecommerce company: what investors should know. According to Benzinga on Sunday, 3 October, "Ula was founded by former employees from Flipkart, Amazon and Procter & Gamble (NYSE: PG). "

More news about Amazon.

5. QUALCOMM (QCOM) – Score: 40.61

Shares of QUALCOMM dropped by a staggering 12.36% in 30 days from $145.52 to $127.53 at 07:33 EST on Wednesday, after five successive sessions in a row of losses. NASDAQ Composite is jumping 1.25% to $14,433.83, after two successive sessions in a row of losses.

QUALCOMM’s last close was $128.71, 23.36% below its 52-week high of $167.94.

The company’s growth estimates for the ongoing quarter and the next is 55.9% and 19.8%, respectively.

QUALCOMM’s Revenue

Year-on-year quarterly revenue growth grew by 64.7%, now sitting on 32.58B for the twelve trailing months.

Volatility

QUALCOMM’s last week, last month’s, and last quarter’s current volatility was a negative 6.17%, a negative 6.17%, and a positive 1.30%, respectively.

QUALCOMM’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.17% (last week), 6.17% (last month), and 1.30% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

QUALCOMM’s stock is considered to be overbought (>=80).

QUALCOMM’s Stock Yearly Top and Bottom Value

QUALCOMM’s stock is valued at $127.53 at 07:33 EST, way under its 52-week high of $167.94 and higher than its 52-week low of $119.10.

QUALCOMM’s Moving Average

QUALCOMM’s value is under its 50-day moving average of $139.25 and below its 200-day moving average of $137.90.

More news about QUALCOMM.

6. Regeneron Pharmaceuticals (REGN) – Score: 40.17

Shares of Regeneron Pharmaceuticals fell by a staggering 19.75% in 30 days from $686.48 to $550.90 at 07:33 EST on Wednesday, after two successive sessions in a row of losses. NASDAQ Composite is jumping 1.25% to $14,433.83, after two consecutive sessions in a row of losses.

Regeneron Pharmaceuticals’s last close was $570.79, 16.87% under its 52-week high of $686.62.

Regeneron Pharmaceuticals’s Sales

Regeneron Pharmaceuticals’s sales growth is 28.6% for the current quarter and 18.3% for the next. The company’s growth estimates for the present quarter and the next is 7.7% and 8%, respectively.

Regeneron Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 163.2%, now sitting on 12.2B for the twelve trailing months.

Volatility

Regeneron Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a negative 9.16%, a negative 9.16%, and a positive 1.41%, respectively.

Regeneron Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 9.16% (last week), 9.16% (last month), and 1.41% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Regeneron Pharmaceuticals’s stock is considered to be overbought (>=80).

Regeneron Pharmaceuticals’s Stock Yearly Top and Bottom Value

Regeneron Pharmaceuticals’s stock is valued at $550.90 at 07:33 EST, way below its 52-week high of $686.62 and way above its 52-week low of $441.00.

Regeneron Pharmaceuticals’s Moving Average

Regeneron Pharmaceuticals’s value is way below its 50-day moving average of $646.04 and under its 200-day moving average of $558.18.

More news about Regeneron Pharmaceuticals.

7. Costco (COST) – Score: 39.07

Shares of Costco slid 3.02% in 30 days from $460.14 to $446.24 at 07:33 EST on Wednesday, after two successive sessions in a row of losses. NASDAQ Composite is rising 1.25% to $14,433.83, after two sequential sessions in a row of losses.

Costco’s last close was $448.33, 4.71% under its 52-week high of $470.49.

The company’s growth estimates for the current quarter and the next is 16.8% and 9.1%, respectively.

Costco’s Revenue

Year-on-year quarterly revenue growth grew by 17.4%, now sitting on 195.93B for the twelve trailing months.

Volatility

Costco’s last week, last month’s, and last quarter’s current volatility was a negative 1.59%, a negative 0.29%, and a positive 0.81%, respectively.

Costco’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.59% (last week), 1.04% (last month), and 0.81% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Costco’s stock is considered to be overbought (>=80).

Costco’s Stock Yearly Top and Bottom Value

Costco’s stock is valued at $446.24 at 07:33 EST, below its 52-week high of $470.49 and way higher than its 52-week low of $307.00.

Costco’s Moving Average

Costco’s value is under its 50-day moving average of $455.58 and way higher than its 200-day moving average of $405.39.

More news about Costco.

8. Tesla (TSLA) – Score: 38.98

Shares of Tesla rose 3.08% in 30 days from $757.27 to $780.59 at 07:33 EST on Wednesday, following the last session’s downward trend. NASDAQ Composite is jumping 1.25% to $14,433.83, after two sequential sessions in a row of losses.

Tesla’s last close was $775.22, 13.9% below its 52-week high of $900.40.

Tesla’s Sales

Tesla’s sales growth is 49.9% for the present quarter and 37.7% for the next. The company’s growth estimates for the present quarter and the next is 81.6% and 102.5%, respectively.

Tesla’s Revenue

Year-on-year quarterly revenue growth grew by 73.6%, now sitting on 35.94B for the twelve trailing months.

Volatility

Tesla’s last week, last month’s, and last quarter’s current volatility was 2.84%, 2.84%, and 1.65%, respectively.

Tesla’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.87% (last week), 2.87% (last month), and 1.65% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Tesla’s stock is considered to be overbought (>=80).

Tesla’s Stock Yearly Top and Bottom Value

Tesla’s stock is valued at $780.59 at 07:33 EST, way under its 52-week high of $900.40 and way higher than its 52-week low of $379.11.

Tesla’s Moving Average

Tesla’s worth is above its 50-day moving average of $736.86 and way above its 200-day moving average of $678.02.

Previous days news about Tesla

  • Tesla stock price and forecast: will TSLA stock go higher as Q3 deliveries surge?. According to FXStreet on Monday, 4 October, "We have been waiting for this one, and we can see from the triangle pattern formed that Tesla stock has been like a coiled spring waiting to explode. ", "The breakout should finally see Tesla make and break $800 and once through there the next resistance and volume does not kick in until $900! "
  • Tesla top wallstreetbets interest heading into new week, amc, wish, tilray and these are other top trends. According to Benzinga on Monday, 4 October, "Read Next: Nikola’s $2B Lawsuit Against Tesla Days Away From Dismissal: What Investors Should Know", "See Also: Elon Musk’s Tesla Accuses Rivian Of Poaching Employees, Stealing Battery Secrets"
  • Tesla stock price and forecast: TSLA green while market red shows relative strength. According to FXStreet on Tuesday, 5 October, "Afederal jury orderedTesla to pay over $130 million in damages to a black former worker, as he was subjected to a racially hostile work environment, according to a report in The Wall Street Journal."While we strongly believe that these facts don’t justify the verdict reached by the jury in San Francisco, we do recognize that in 2015 and 2016 we were not perfect," Tesla said. ", "Facebook slumped nearly 5%, Apple plunged nearly 2.5%, Amazon was down nearly 3%, but Tesla was one of the few green beacons in a sea of red. "
  • A safety agency finds no cause to investigate Tesla battery safety.. According to The New York Times on Monday, 4 October, "The available data indicate that noncrash battery fires in Tesla vehicles are rare events," the agency wrote.", "The federal government’s top auto-safety regulator has declined to open a formal investigation into the fire risk in Tesla vehicles with fully charged batteries after finding no relevant incidents in the United States in the last two years."
  • Tesla inflicts more pain on short sellers. According to Bloomberg Quint on Monday, 4 October, "The stock has since soared 1,182% as the shift to electric vehicles picked up and Tesla solidified its first-entrant advantage.", "While there are many competitors in the EV space, Tesla continues to dominate market share as evidenced again this quarter while battling through the chip shortage," Ives said."

More news about Tesla.

9. Moderna (MRNA) – Score: 37.98

Shares of Moderna dropped by a staggering 25.66% in 30 days from $446.74 to $332.11 at 07:33 EST on Wednesday, after two successive sessions in a row of losses. NASDAQ Composite is rising 1.25% to $14,433.83, after two successive sessions in a row of losses.

Moderna’s last close was $341.09, 31.44% under its 52-week high of $497.49.

Moderna’s Sales

Moderna’s sales growth is 8216.6% for the present quarter and 1202.8% for the next. The company’s growth estimates for the present quarter and the next is 1694.9% and 1681.2%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.

Volatility

Moderna’s last week, last month’s, and last quarter’s current volatility was a negative 10.55%, a negative 10.55%, and a positive 4.83%, respectively.

Moderna’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 10.55% (last week), 10.55% (last month), and 4.83% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be overbought (>=80).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $332.11 at 07:33 EST, way below its 52-week high of $497.49 and way higher than its 52-week low of $65.49.

Moderna’s Moving Average

Moderna’s value is way under its 50-day moving average of $405.59 and way above its 200-day moving average of $266.13.

Previous days news about Moderna

  • EU drug panel backs boosters of Pfizer, Moderna for vulnerable. According to Bloomberg Quint on Monday, 4 October, "A European Union advisory committee endorsed the use of a third dose of the Covid-19 vaccines developed by Pfizer Inc. and Moderna Inc. for people with severely weakened immune systems.", "The U.S. Food and Drug Administration may soon authorize half-dose boosters of the Moderna vaccine, setting the stage to further widen the U.S. booster campaign after earlier authorization of the extra Pfizer-BioNTech dose."
  • Why this investor keeps buying Moderna shares as the stock falls. According to Benzinga on Monday, 4 October, "Short Hills Capital’s Steve Weiss keepsadding to his Moderna Inc (NASDAQ:MRNA) position as the stock continues to fall, he said Monday on CNBC’s "Fast Money Halftime Report.", "MRNA Price Action: Moderna has traded as high as $497.49 and as low as $65.48 over a 52-week period."

More news about Moderna.

10. JD.com (JD) – Score: 37.8

Shares of JD.com dropped by a staggering 14.48% in 30 days from $83.75 to $71.62 at 07:33 EST on Wednesday, after four consecutive sessions in a row of losses. NASDAQ Composite is rising 1.25% to $14,433.83, after two successive sessions in a row of losses.

JD.com’s last close was $70.02, 35.34% under its 52-week high of $108.29.

JD.com’s Sales

JD.com’s sales growth is 27.4% for the current quarter and 25.8% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 39.6% and a negative 39.1%, respectively.

JD.com’s Revenue

Year-on-year quarterly revenue growth grew by 39%, now sitting on 802.77B for the twelve trailing months.

Volatility

JD.com’s last week, last month’s, and last quarter’s current volatility was a negative 6.86%, a negative 6.86%, and a positive 2.73%, respectively.

JD.com’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.86% (last week), 6.86% (last month), and 2.73% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

JD.com’s stock is considered to be overbought (>=80).

JD.com’s Stock Yearly Top and Bottom Value

JD.com’s stock is valued at $71.62 at 07:33 EST, way under its 52-week high of $108.29 and way higher than its 52-week low of $61.65.

JD.com’s Moving Average

JD.com’s worth is below its 50-day moving average of $74.66 and below its 200-day moving average of $74.94.

More news about JD.com.

LEAVE A REPLY

Please enter your comment!
Please enter your name here